Real‐world safety of nivolumab in patients with non‐small‐cell lung cancer in Japan: Postmarketing surveillance

Postmarketing surveillance of Japanese patients with unresectable, previously treated, advanced or recurrent non‐small‐cell lung cancer treated with nivolumab was undertaken during the conditional approval period. The study aim was to evaluate the occurrence of treatment‐related adverse events of ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Nobuyuki, Nakanishi, Yoichi, Gemma, Akihiko, Nakagawa, Kazuhiko, Sakamoto, Takahiko, Akamatsu, Ayumi, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586674/
https://www.ncbi.nlm.nih.gov/pubmed/34431585
http://dx.doi.org/10.1111/cas.15117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586674/
https://www.ncbi.nlm.nih.gov/pubmed/34431585
http://dx.doi.org/10.1111/cas.15117

Ejemplares similares